Breaking News

You are here » Indian-Commodity  :  Commodities  :  Jeera  :  Jeera futures trade modestly lower on NCDEX

23-Feb2018

Jeera futures trade modestly lower on NCDEX

Jeera futures traded modestly lower on NCDEX, as speculators locked in their profits at prevailing higher prices amid muted buys and on reports of higher arrivals in the physical market. 

The contract for March delivery was trading at Rs 15325.00, declined by 0.87% or Rs 135.00 from its previous closing of Rs 15460.00. The open interest of the contract stood at 9762 lots.

The contract for April delivery was trading at Rs 15525.00, dipped 0.89 % or Rs 140.00 from its previous closing of Rs 15665.00. The open interest of the contract stood at 2922 lots on NCDEX.


Related News

View all news

Jeera futures trade lower on profit booking

Jeera futures traded lower on NCDEX, due to profit booking by participants after the prices peaked counting on improving physical domestic and exports demands from China and Bangladesh. Moreover, anticipation......

Jeera futures trade higher on firm demand

Jeera futures traded higher on NCDEX, due to scanty rainfall in producing centres of Gujarat and Rajasthan, which might impact cumin production this year. Moreover, firm spot demand from domestic......

Jeera futures trade up on NCDEX

Jeera futures traded up on NCDEX, due to concerns on impact of overall output amid water shortage in producing centres of Gujarat and Rajasthan. Besides, pick-up in demand from domestic and exports markets......

Top News

View all news

Aurobindo Pharma, TVS Motor and Lupin to see some action today

Aurobindo Pharma's wholly owned subsidiary -- Aurobindo Pharma USA Inc., has entered into an agreement to acquire a product under development and related assets from 'Advent Pharmaceuticals Pty, Australia,......

TVS Motor launches TVS Apache RTR 160 4V in Bangladesh

TVS Motor Company has launched the TVS Apache RTR 160 4V in Bangladesh. A testimony to the racing legacy of the TVS Apache RTR series, the TVS Apache RTR 160 4V will be the flagship offering of the brand......

Aurobindo Pharma's arm enters into agreement with Advent Pharma

Aurobindo Pharma's wholly owned subsidiary -- Aurobindo Pharma USA Inc. -- has entered into an agreement to acquire a product under development and related assets from Advent Pharmaceuticals Pty, Australia,......